We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPT icon
76
Camden Property Trust
CPT
$11B
– –
-104,812
Closed -$12.5M
CRC icon
77
California Resources
CRC
$4.67B
– –
-18,026
Closed -$693K
CRNX icon
78
Crinetics Pharmaceuticals
CRNX
$8.9B
– –
-90,460
Closed -$1.78M
CRWD icon
79
CrowdStrike
CRWD
$211B
– –
-120,000
Closed -$4.94M
CTRE icon
80
CareTrust REIT
CTRE
$9.72B
– –
-169,179
Closed -$3.06M
CUBE icon
81
CubeSmart
CUBE
$9.42B
– –
-198,176
Closed -$7.94M
DAL icon
82
Delta Air Lines
DAL
$60.5B
– –
-104,855
Closed -$2.94M
DAL icon
83
PUT
Delta Air Lines
DAL
$60.5B
– –
-28,200
Closed -$382K
DAWN
84
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-37,000
Closed -$741K
DE icon
85
Deere & Co
DE
$166B
– –
-15,800
Closed -$5.28M
DHI icon
86
D.R. Horton
DHI
$40.8B
– –
-65,534
Closed -$4.41M
DINO icon
87
HF Sinclair
DINO
$14.7B
– –
-54,526
Closed -$2.94M
DKNG icon
88
DraftKings
DKNG
$11B
– –
-250,000
Closed -$3.79M
DKNG icon
89
PUT
DraftKings
DKNG
$11B
– –
-100,000
Closed -$86K
DOC icon
90
Healthpeak Properties
DOC
$14.5B
– –
-91,011
Closed -$2.09M
DOCS icon
91
Doximity
DOCS
$3.77B
– –
-90,000
Closed -$2.72M
DTI icon
92
Drilling Tools International
DTI
$82.6M
– –
-233,953
Closed -$2.35M
DTIL icon
93
Precision BioSciences
DTIL
$191M
– –
-16,417
Closed -$640K
DVN icon
94
Devon Energy
DVN
$49.7B
– –
-85,761
Closed -$5.16M
DY icon
95
Dycom Industries
DY
$12B
– –
-22,377
Closed -$2.14M
DYN icon
96
Dyne Therapeutics
DYN
$4.83B
– –
-176,490
Closed -$2.24M
EGP icon
97
EastGroup Properties
EGP
$10.8B
– –
-103,547
Closed -$14.9M
ELS icon
98
Equity Lifestyle Properties
ELS
$12.5B
– –
-293,210
Closed -$18.4M
EMN icon
99
Eastman Chemical
EMN
$8.4B
– –
-23,941
Closed -$1.7M
EMR icon
100
Emerson Electric
EMR
$87.5B
– –
-156,582
Closed -$11.5M
2 3
4
5 6

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.